stella
beta
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy — Stella
Recruiting
Back to Systemic Lupus Erythematosus (SLE) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov